Drug intelligence / Profile preview

Huoxue Huatan Formula

Development stage: Unknown
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Huoxue Huatan Formula is a traditional Chinese medicine (TCM) herbal preparation, typically administered as granules or a decoction. It is being developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment and prevention of ventricular remodeling following myocardial infarction. The formula is specifically indicated for patients presenting with "True Cardialgia" and "Phlegm-Stasis Interlocking Syndrome" in TCM diagnostics. Its therapeutic approach involves "Huoxue" (promoting blood circulation to remove blood stasis) and "Huatan" (resolving phlegm). Research into its mechanism of action includes the modulation of gut microbiota and metabolic pathways to mitigate cardiac structural changes post-infarction.

Other names: Huoxue Huatan Granules

Beyond the preview

Go deeper on Huoxue Huatan Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huoxue Huatan Formula.

Explore the full profile